Journal
JOURNAL OF HYPERTENSION
Volume 27, Issue -, Pages S36-S39Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.hjh.0000354519.67451.96
Keywords
angiotensin receptor blockers; antihypertensive treatment; atrial fibrillation; blood pressure control; left ventricular hypertrophy; new-onset diabetes
Categories
Ask authors/readers for more resources
Prevention of diabetes represents an important therapeutic goal in current cardiovascular risk reduction strategies. Blockade of the renin-angiotensin system has been shown to markedly reduce the incidence of new-onset diabetes in different patient populations. Recent results from three large clinical endpoint trials with the angiotensin-II receptor blocker telmisartan regarding new-onset diabetes, atrial fibrillation, and left ventricular hypotrophy will be discussed. J Hypertens 27 (suppl 2): S36-S39 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available